Dupixent Lymphoma Lawsuit in Virginia
Last Updated: August 7, 2026
Virginia is one of the most challenging states for pharmaceutical plaintiffs due to its strict two-year statute of limitations and its status as one of the few states that does NOT recognize the discovery rule for most tort claims. This means the clock typically starts running when the injury occurs, not when it is discovered, making early legal consultation essential. The Eastern District of Virginia, known as the 'Rocket Docket' for its fast case processing, and the Western District provide the federal litigation venues for the state's 8.6 million residents.
Dupixent (dupilumab) is an injected biologic prescribed mainly for severe eczema. Lawsuits allege that it can cause or accelerate cutaneous T-cell lymphoma, and separately that it can mask the early symptoms of one already present and delay the diagnosis. Federal cases are coordinated in MDL 3180 in the D.N.J. In Virginia, the personal injury statute of limitations is 2 years and the product liability deadline is 2 years. These are allegations under examination, not established findings. NuLegal reviews these claims at no cost and connects qualified claimants with trial counsel.
Dupixent Lymphoma Claims in Virginia
Dupixent is prescribed most often for moderate-to-severe atopic dermatitis. The claims in this litigation allege two separate things: that the medication may cause or accelerate a cutaneous T-cell lymphoma, and that it may suppress the skin symptoms of one a patient already has — so the rash looks like eczema responding to treatment, the biopsy is not ordered, and the lymphoma is identified later. Both are allegations under active litigation, not established findings.
For a Virginia resident, two things decide whether a claim is viable: the medical facts and the filing deadline. The medical side is whether Dupixent was prescribed and whether a lymphoma was diagnosed — in either order. The legal side is Virginia's statute of limitations, and specifically how this state treats the discovery rule, discussed below.
Virginia legal landscape: Virginia is one of the few states that still applies contributory negligence as a complete bar to recovery. The state does not recognize strict liability for product defect claims — plaintiffs must proceed under negligence or breach of warranty theories. These rules make Virginia one of the most defense-friendly jurisdictions for pharmaceutical litigation. These doctrines shape how a product liability claim about a prescription biologic is pleaded and what a claimant must prove, which is why the analysis differs meaningfully from state to state.
Residents in Virginia Beach, Norfolk, Richmond, Arlington, and Chesapeake and the surrounding areas would typically obtain the pathology report from the facility that performed the skin biopsy, and the prescription history from the pharmacy or the prescribing dermatologist. Those two documents are the ones a review eventually turns on.
Virginia Statute of Limitations
In Virginia, the personal injury statute of limitations is 2 years and the product liability deadline is 2 years. A Dupixent claim is generally pleaded as a product liability claim about a prescription medication, so both deadlines can be relevant depending on how the claim is framed.
Virginia applies the discovery rule narrowly in product liability cases, so the filing window may be measured from the diagnosis itself rather than from the point at which you connected it to the medication. In this litigation that is a materially harder timeline than it sounds: the connection between Dupixent and a cutaneous T-cell lymphoma is not something a prescriber typically raises, and a claimant here may be measured against a clock that started before she had any reason to look. It is a reason to have the dates reviewed sooner rather than later.
Do not assume a deadline has passed without having it checked. How the personal injury and product liability statutes interact, whether the discovery rule applies to your facts, and whether any tolling doctrine is available are questions that turn on the specifics of your case.
Personal Injury SOL
2 years
Product Liability SOL
2 years
Discovery Rule
Limited
Where a Virginia Case Is Filed
A Virginia claim can be brought in the Virginia Circuit Courts at the state level, or in federal court. The federal districts covering Virginia are the Eastern District of Virginia, Western District of Virginia.
A case filed in or removed to federal court is transferred by the Judicial Panel on Multidistrict Litigation into MDL 3180, pending in the D.N.J. before Judge Zahid N. Quraishi. That transfer is for coordinated pretrial proceedings — discovery, expert practice, and eventually bellwether trials. It groups cases that share common questions of fact; it decides nothing about whether any of them has merit. Cases that do not resolve during that process can be remanded to the district they came from for trial.
Transfer to New Jersey does not require a Virginia claimant to travel there. Counsel handles the filings and proceedings.
State court
Virginia Circuit Courts
Federal districts
Eastern District of Virginia, Western District of Virginia
What a Virginia Review Looks At
A review turns on four facts. If you are unsure about any of them, say so — an unknown answer routes the file to a person rather than closing it.
You were treated with Dupixent
You were prescribed Dupixent or dupilumab, whether in Virginia or elsewhere. Your pharmacy record names it if you are not certain of the brand.
A lymphoma was diagnosed
You were diagnosed with a lymphoma. Many people are told a subtype name — mycosis fungoides or Sézary syndrome — rather than the word lymphoma.
The two dates, in either order
Roughly what year the medication started and roughly what year the diagnosis came. A diagnosis that came first goes to the delayed-diagnosis theory rather than ruling you out.
Within the filing deadline
The claim falls inside Virginia's window (2 years for personal injury, 2 years for product liability). The discovery rule is applied narrowly here, so the timing should be checked early.
Virginia Dupixent Lymphoma FAQ
What is the statute of limitations for a Dupixent lymphoma claim in Virginia?
Virginia applies a 2-year statute of limitations to personal injury claims and a 2-year one to product liability claims. Virginia applies the discovery rule narrowly, so the deadline may be measured from the diagnosis itself rather than from the point you connected it to the medication. In a claim where that connection is typically learned late, that is a materially tighter timeline and a reason to have the dates checked now rather than later. Deadlines are strict and missing one can bar a claim permanently.
Where would a Virginia Dupixent case be filed?
A Virginia claimant's case would be filed either in the Virginia Circuit Courts at the state level or in federal court. The federal districts covering Virginia are the Eastern District of Virginia, Western District of Virginia. Federal Dupixent cases are transferred into MDL 3180 in the D.N.J. before Judge Zahid N. Quraishi for coordinated pretrial proceedings, and cases that do not resolve there can be remanded to their home district for trial.
I was diagnosed before I started Dupixent. Does that end a Virginia claim?
Not automatically. These lawsuits plead two theories, and the second is that Dupixent can mask the early skin symptoms of a cutaneous T-cell lymphoma a patient already has, so the biopsy is not ordered and the disease is identified later than it would otherwise have been. That theory is specifically about patients whose lymphoma predates the prescription. The screening asks for both years and routes the file to a person rather than closing it.
How does Virginia product liability law apply to a prescription biologic?
Virginia is one of the few states that still applies contributory negligence as a complete bar to recovery. The state does not recognize strict liability for product defect claims — plaintiffs must proceed under negligence or breach of warranty theories. These rules make Virginia one of the most defense-friendly jurisdictions for pharmaceutical litigation. A Dupixent claim is a product liability claim about a prescription medication, so these Virginia doctrines govern how the claim is framed and what a claimant has to prove.
What do I need before a Virginia case review?
Nothing formal. It helps to know roughly what year you started Dupixent and roughly what year you were diagnosed, and which dermatologist or oncologist has the biopsy report. If you do not have those details, the screening accepts "not sure" — an unknown answer sends the file to a person rather than closing it. The pathology report, usually held by the facility that did the biopsy in Virginia Beach, Norfolk, Richmond, Arlington, and Chesapeake or nearby, is the document that eventually settles the diagnosis.
Do I need to travel to New Jersey to bring a claim?
No. MDL 3180 is where federal Dupixent cases are coordinated for pretrial work, but claimants are not required to appear there. Counsel handles filings and proceedings. A Virginia resident's case would be filed by counsel and coordinated from wherever it is filed.
What does a Virginia case review cost?
Nothing. NuLegal's review is free and carries no obligation. NuLegal reviews the claim and, where it qualifies, connects the claimant with trial counsel handling this litigation. Attorneys in this litigation work on a contingency fee basis. Submitting the form does not create an attorney-client relationship.
Related Resources
Virginia Residents: Don't Wait
Virginia's filing deadline is 2 years for personal injury claims. A free, no-obligation review takes a few minutes and tells you whether your claim fits the current filings.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.